Three-Season Influenza Vaccine Immune Response Data

A three-season (2022–2025) study of 1,328 participants aged 9–89 years receiving six influenza vaccine types. Engin Berber collected serum samples tested for hemagglutination inhibition (HAI) activity against vaccine and historical strains before and after vaccination. Seroprotection and seroconversion rates were analyzed by age group and vaccine platform.

Use Cases

• Analyze seroconversion rates based on vaccine type and recipient age.
• Compare hemagglutination inhibition titers based on vaccine platform.
• Study the effect of repeated annual vaccination on antibody boosting.
• Evaluate seroprotection rates based on age group and immune history.
• Associate baseline antibody titers with post-vaccination response.

Strengths

• Data spans three consecutive seasons (2022–2025).
• Includes 1,328 participants across a wide age range (9–89 years).
• Compares six distinct vaccine formulations.
• Contains pre- and post-vaccination serum measurements.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment.
• Data may reflect temporal bias inherent to the specific three-season study period.

Provenance

Source

Engin Berber

Collection Method

Clinical study collecting serum samples and testing for hemagglutination inhibition activity.

Time Range

2022–2025

Freshness

Last updated 2026-04-16 17:37:33; freshness should be verified.